|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
68,990,000 |
Market
Cap: |
N/A |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0 - $0 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Bicycle Therapeutics is a holding company. Through its subsidiaries, Co. is a clinical-stage biopharmaceutical company developing a class of medicines, which it refers to as Bicycles. Bicycles are a therapeutic modality combining the pharmacology associated with a biologic with the manufacturing and pharmacokinetic properties of a small molecule. Co. is evaluating BT5528, a Bicycle Toxin Conjugate (BTC) targeting Ephrin type-A receptor 2, BT8009, a BTC targeting Nectin-4, and BT7480, a Bicycle tumor-targeted immune cell agonist® targeting Nectin-4 and agonizing CD137. In addition, BT1718, a BTC that is being developed to target tumors that express Membrane Type 1 matrix metalloproteinase.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
1,485,397 |
1,485,397 |
Total Buy Value |
$0 |
$0 |
$21,230,385 |
$21,230,385 |
Total People Bought |
0 |
0 |
1 |
1 |
Total Buy Transactions |
0 |
0 |
2 |
2 |
Total Shares Sold |
11,052 |
21,651 |
77,303 |
118,197 |
Total Sell Value |
$92,962 |
$170,024 |
$960,029 |
$1,767,537 |
Total People Sold |
7 |
7 |
9 |
10 |
Total Sell Transactions |
12 |
23 |
50 |
76 |
End Date |
2025-07-20 |
2025-04-18 |
2024-10-18 |
2023-10-19 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Skynner Michael |
CHIEF TECHNOLOGY OFFICER |
|
2025-10-03 |
4 |
S |
$8.41 |
$8,225 |
D/D |
(978) |
118,277 |
|
- |
|
Hannay Michael Charles Ferguson |
CHIEF PROD & SUPPLY CHAIN OFF |
|
2025-10-03 |
4 |
S |
$8.41 |
$2,103 |
D/D |
(250) |
53,102 |
|
- |
|
Thompson Travis Alvin |
CHIEF ACCOUNTING OFFICER |
|
2025-10-03 |
4 |
S |
$8.41 |
$866 |
D/D |
(103) |
31,197 |
|
- |
|
Milnes Alistair |
CHIEF OPERATING OFFICER |
|
2025-10-03 |
4 |
S |
$8.41 |
$8,225 |
D/D |
(978) |
93,377 |
|
- |
|
Lee Kevin |
CHIEF EXECUTIVE OFFICER |
|
2025-10-03 |
4 |
S |
$8.41 |
$27,173 |
D/D |
(3,231) |
475,310 |
|
- |
|
Skynner Michael |
CHIEF TECHNOLOGY OFFICER |
|
2025-10-02 |
4 |
S |
$8.40 |
$6,922 |
D/D |
(824) |
119,255 |
|
- |
|
Hannay Michael Charles Ferguson |
CHIEF PROD & SUPPLY CHAIN OFF |
|
2025-10-02 |
4 |
S |
$8.40 |
$3,973 |
D/D |
(473) |
53,352 |
|
- |
|
Thompson Travis Alvin |
CHIEF ACCOUNTING OFFICER |
|
2025-10-02 |
4 |
S |
$8.40 |
$1,856 |
D/D |
(221) |
31,300 |
|
- |
|
Milnes Alistair |
CHIEF OPERATING OFFICER |
|
2025-10-02 |
4 |
S |
$8.40 |
$9,635 |
D/D |
(1,147) |
94,355 |
|
- |
|
Young Alethia |
Chief Financial Officer |
|
2025-10-02 |
4 |
AS |
$8.40 |
$4,103 |
D/D |
(482) |
44,704 |
|
- |
|
Swanton Robert Charles |
|
|
2025-10-02 |
4 |
AS |
$8.55 |
$872 |
D/D |
(102) |
15,487 |
|
- |
|
Lee Kevin |
CHIEF EXECUTIVE OFFICER |
|
2025-10-02 |
4 |
S |
$8.40 |
$19,009 |
D/D |
(2,263) |
478,541 |
|
- |
|
Hoppenot Herve |
|
|
2025-09-08 |
4 |
A |
$0.00 |
$0 |
D/D |
12,500 |
12,500 |
|
- |
|
Dansey Roger D |
|
|
2025-09-08 |
4 |
A |
$0.00 |
$0 |
D/D |
12,500 |
12,500 |
|
- |
|
Swanton Robert Charles |
|
|
2025-08-12 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,089 |
|
- |
|
Swanton Robert Charles |
|
|
2025-08-12 |
4 |
A |
$0.00 |
$0 |
D/D |
12,500 |
15,589 |
|
- |
|
Milnes Alistair |
CHIEF OPERATING OFFICER |
|
2025-07-03 |
4 |
S |
$7.44 |
$7,187 |
D/D |
(966) |
95,502 |
|
- |
|
Thompson Travis Alvin |
CHIEF ACCOUNTING OFFICER |
|
2025-07-03 |
4 |
S |
$7.44 |
$744 |
D/D |
(100) |
31,521 |
|
- |
|
Skynner Michael |
CHIEF TECHNOLOGY OFFICER |
|
2025-07-03 |
4 |
S |
$7.44 |
$7,187 |
D/D |
(966) |
120,079 |
|
- |
|
Hannay Michael Charles Ferguson |
CHIEF PROD & SUPPLY CHAIN OFF |
|
2025-07-03 |
4 |
S |
$7.44 |
$1,845 |
D/D |
(248) |
53,825 |
|
- |
|
Lee Kevin |
CHIEF EXECUTIVE OFFICER |
|
2025-07-03 |
4 |
S |
$7.44 |
$23,756 |
D/D |
(3,193) |
480,804 |
|
- |
|
Young Alethia |
Chief Financial Officer |
|
2025-07-02 |
4 |
S |
$7.09 |
$1,446 |
D/D |
(204) |
45,186 |
|
- |
|
Milnes Alistair |
CHIEF OPERATING OFFICER |
|
2025-07-02 |
4 |
S |
$7.09 |
$8,146 |
D/D |
(1,149) |
96,468 |
|
- |
|
Thompson Travis Alvin |
CHIEF ACCOUNTING OFFICER |
|
2025-07-02 |
4 |
S |
$7.09 |
$1,461 |
D/D |
(206) |
31,621 |
|
- |
|
Skynner Michael |
CHIEF TECHNOLOGY OFFICER |
|
2025-07-02 |
4 |
S |
$7.09 |
$5,849 |
D/D |
(825) |
121,045 |
|
- |
|
314 Records found
|
|
Page 1 of 13 |
|
|